Arcadia Biosciences Valuation
| RKDA Stock | USD 2.06 0.03 1.48% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Arcadia Biosciences shows a prevailing Real Value of $5.23 per share. The current price of the firm is $2.06. Our model approximates the value of Arcadia Biosciences from analyzing the firm fundamentals such as profit margin of (2.62) %, and Return On Equity of -0.78 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Arcadia Biosciences' valuation include:
Price Book 0.208 | Enterprise Value -8 M | Enterprise Value Ebitda 0.5865 | Price Sales 0.5012 | Enterprise Value Revenue 0.016 |
Undervalued
Today
Please note that Arcadia Biosciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Arcadia Biosciences is based on 3 months time horizon. Increasing Arcadia Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Arcadia Biosciences is useful when determining the fair value of the Arcadia stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Arcadia Biosciences. Since Arcadia Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arcadia Stock. However, Arcadia Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.06 | Real 5.23 | Target 15.0 | Hype 2.01 | Naive 2.0 |
The real value of Arcadia Stock, also known as its intrinsic value, is the underlying worth of Arcadia Biosciences Company, which is reflected in its stock price. It is based on Arcadia Biosciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Arcadia Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Arcadia Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Arcadia Biosciences helps investors to forecast how Arcadia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arcadia Biosciences more accurately as focusing exclusively on Arcadia Biosciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Arcadia Biosciences' intrinsic value based on its ongoing forecasts of Arcadia Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Arcadia Biosciences' closest peers. When choosing an evaluation method for Arcadia Biosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Arcadia Biosciences Investments |
|
Arcadia Valuation Trend
Knowing Arcadia Biosciences' actual value is paramount for traders to make sound investment determinations. Arcadia Biosciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Arcadia Biosciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Arcadia Biosciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Arcadia Market Cap
Arcadia Biosciences is rated below average in market capitalization category among related companies. Market capitalization of Consumer Staples industry is at this time estimated at about 1.28 Billion. Arcadia Biosciences adds roughly 2.93 Million in market capitalization claiming only tiny portion of stocks in Consumer Staples industry.Arcadia Biosciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Arcadia Biosciences's current stock value. Our valuation model uses many indicators to compare Arcadia Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arcadia Biosciences competition to find correlations between indicators driving Arcadia Biosciences's intrinsic value. More Info.Arcadia Biosciences is rated fourth in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.04 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Arcadia Biosciences is roughly 23.27 . The current year's Price To Book Ratio is expected to grow to 0.32. Comparative valuation analysis is a catch-all model that can be used if you cannot value Arcadia Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arcadia Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arcadia Biosciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Arcadia Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Arcadia Biosciences and how it compares across the competition.
About Arcadia Biosciences Valuation
The stock valuation mechanism determines the current worth of Arcadia Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Arcadia Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Arcadia Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Arcadia Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Arcadia Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcadia Biosciences. We calculate exposure to Arcadia Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arcadia Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 M | 2.1 M | |
| Pretax Profit Margin | (2.47) | (2.59) | |
| Operating Profit Margin | (2.60) | (2.73) | |
| Net Loss | (2.62) | (2.75) | |
| Gross Profit Margin | 0.38 | 0.57 |
8 Steps to conduct Arcadia Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Arcadia Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Arcadia Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Arcadia Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Arcadia Biosciences' revenue streams: Identify Arcadia Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Arcadia Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Arcadia Biosciences' growth potential: Evaluate Arcadia Biosciences' management, business model, and growth potential.
- Determine Arcadia Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Arcadia Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Arcadia Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Arcadia Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.2 M | |
| Quarterly Earnings Growth Y O Y | -0.626 |
Arcadia Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Arcadia Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Arcadia we look at many different elements of the entity such as Arcadia's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Arcadia Biosciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Arcadia Biosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Arcadia Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Arcadia Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Arcadia Biosciences' worth.When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.Note that the Arcadia Biosciences information on this page should be used as a complementary analysis to other Arcadia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Arcadia Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.63) | Earnings Share (10.64) | Revenue Per Share 4.309 | Quarterly Revenue Growth 0.573 | Return On Assets (0.34) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.